Dr. Hedrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8730 Alden Dr.
Thalians Ste E137
Los Angeles, CA 90048Phone+1 310-423-3465Fax+1 310-423-8397
Summary
- Dr. Rebecca Hedrick is a highly experienced psychiatrist based in Los Angeles, with a subspecialty in Child & Adolescent Psychiatry. Her education began with a BA in Psychology and Spanish from Vanderbilt University and continued with her MD from the University of Louisville School of Medicine. She furthered her training with a Psychiatry Residency and a Child and Adolescent Psychiatry Fellowship, both at the University of California, Irvine. Dr. Hedrick has held significant roles at the UCI Medical Center and is currently the Director of Consultation Liaison Psychiatry and an Associate Professor at Cedars-Sinai Medical Center. She has demonstrated expertise in addiction medicine, behavioral neurology/neuropsychiatry, and liaison psychiatry. With numerous publications to her name, Dr. Hedrick has made notable contributions to fields such as depressive symptoms in heart failure patients, and the treatment of severe mental illness in oncology patients.
Education & Training
- University of California (Irvine)Fellowship, Child and Adolescent Psychiatry, 2006 - 2008
- University of California (Irvine)Residency, Psychiatry, 2002 - 2008
- University of Louisville School of MedicineClass of 2002
- Vanderbilt UniversityBA, Psychology, Spanish, Magna Cum Laude, 1993 - 1997
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3.Ashley Meyer, Kyla Truman, Jayant Totlani, Catherine William, Haze Brown
International Journal of Psychiatry in Medicine. 2024-12-19 - Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.Waguih William IsHak, Ashley Meyer, Luiza Freire, Jayant Totlani, Nathalie Murphy
Innovations in Clinical Neuroscience. 2024-09-01 - Comparative Effectiveness of Psychotherapy vs Antidepressants for Depression in Heart Failure: A Randomized Clinical Trial.Waguih William IsHak, Michele A Hamilton, Samuel Korouri, Marcio A Diniz, James Mirocha
JAMA Network Open. 2024-01-02
Press Mentions
- Cedars-Sinai’s Music for Healing Program Provides Medical BenefitsMay 17th, 2019
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: